Cingulate Inc. (CING) Financials
CING Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 33.1 billion | 9.6 million |
| March 31, 2026 | 30.9 million | 12.0 million |
| Dec. 31, 2025 | 15.1 million | 12.6 million |
| Sept. 30, 2025 | 10.5 million | 7.0 million |
CING Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -12.9 billion | 954.7 million |
| March 31, 2026 | -7.0 million | 593100 |
| Dec. 31, 2025 | -3.8 million | 385965 |
| Sept. 30, 2025 | -4.2 million | 592824 |
CING Net Income
No data available :(
CING Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 28.4 billion | 968.5 million | - |
| March 31, 2026 | 25.9 million | - | 1.3 million |
| Dec. 31, 2025 | 11.0 million | 1.2 million | 1.3 million |
| Sept. 30, 2025 | 6.1 million | - | 1.4 million |
CING Shares Outstanding
CING Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 128.2 million | 1.5 million | 3.9 million | - |
| March 31, 2026 | 61180 | 2.2 million | 5.7 million | - |
| Dec. 31, 2025 | 156213 | 2.0 million | 3.6 million | - |
| Sept. 30, 2025 | 4 | 2.8 million | 3.1 million | - |
CING Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 121185 |
| Dec. 31, 2025 | - | -419062 |
| Sept. 30, 2025 | - | 106782 |
CING
Price: $4.72
52 week price:
Earnings Per Share: -3.56 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 16900
Market Capitalization: 65.9 million